Walden Biosciences Funding: $51M Raised, Series A (2020)
Walden Biosciences is based in Cambridge. It has raised $51M in total funding. Latest round: Series A.
Walden Biosciences funding overview
Walden Biosciences is based in Cambridge. Walden Biosciences has raised $51M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2020. The round record for Walden Biosciences runs through 2020; nothing later has been disclosed. Investors on record include ARCH Venture Partners, UCB Ventures, Huizenga Capital Management. 3 distinct backers are named across the disclosed rounds.
Walden Biosciences at a glance
Total raised
$51M
Latest round
Series A
Latest round date
January 2020
Headquarters
Cambridge
Notable investors
ARCH Venture Partners, UCB Ventures, Huizenga Capital Management
Frequently asked about Walden Biosciences funding
How much has Walden Biosciences raised?
Walden Biosciences has raised $51M in total disclosed funding across the rounds on record.
Who has invested in Walden Biosciences?
ARCH Venture Partners, UCB Ventures, Huizenga Capital Management are named among the investors backing Walden Biosciences.
What was the latest Walden Biosciences funding round?
The most recent disclosed round is a Series A, announced in January 2020.
Where is Walden Biosciences based?
Walden Biosciences is based in Cambridge.
When did Walden Biosciences last raise?
The last disclosed Walden Biosciences round closed in January 2020 at Series A.
Totals shown for Walden Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
